molecular diagnostics

Disruptive technologies are changing the way we approach patient diagnostics and treatment

Robust IT solutions for more mainstream molecular testing

New testing platforms have the potential to transform clinical diagnostics and treatment

Why a broader range of general-purpose reagents are needed for the next pandemic

CRISPR-based diagnostics can offer quick and accurate nucleic acid testing for infectious and noninfectious diseases

CRISPR-Cas systems can improve the speed, sensitivity, and specificity of diagnostic tests, but are they ready for prime time?

PET imaging using 18F-fluoroestradiol can help to determine which patients could benefit from treatments that could spare them from unnecessary chemotherapy

If mutations occur in the part of the virus’s genome assessed by a test, the mutations can cause false negative results

Rapid, multiplex molecular tests will give labs flexibility and scalability as they plan for the upcoming flu season

More than 100 clinical laboratory professionals across the US provided feedback on COVID-19 diagnostic testing environment